The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 10, 2026

Filed:

Apr. 04, 2023
Applicants:

Tufts Medical Center, Inc., Boston, MA (US);

Abiomed, Inc., Danvers, MA (US);

Inventors:

Navin K. Kapur, Boston, MA (US);

Richard H. Karas, Franklin, MA (US);

Noam Josephy, Danvers, MA (US);

Assignees:

Tufts Medical Center, Inc., Boston, MA (US);

Abiomed, Inc., Danvers, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 60/00 (2021.01); A61M 60/113 (2021.01); A61M 60/117 (2021.01); A61M 60/13 (2021.01); A61M 60/139 (2021.01); A61M 60/148 (2021.01); A61M 60/17 (2021.01); A61M 60/216 (2021.01); A61M 60/295 (2021.01); A61M 60/38 (2021.01); A61M 60/422 (2021.01); A61M 60/857 (2021.01);
U.S. Cl.
CPC ...
A61M 60/148 (2021.01); A61M 60/113 (2021.01); A61M 60/117 (2021.01); A61M 60/13 (2021.01); A61M 60/139 (2021.01); A61M 60/17 (2021.01); A61M 60/216 (2021.01); A61M 60/295 (2021.01); A61M 60/38 (2021.01); A61M 60/422 (2021.01); A61M 60/857 (2021.01);
Abstract

We provide herein a method of preventing or limiting the effects of heart failure in a human patient that has sustained myocardial infarction by reducing maladaptive cardiac remodeling in the patient. The method comprises percutaneously inserting a transvalvular blood pump, comprising a rotor and a cannula, into the patient's vasculature and positioning the cannula across the aortic valve of the patient's heart, with a distal end of the cannula located in the left ventricle of the heart and a proximal end of the pump located in the aorta. The method then comprises, prior to reperfusing the heart, operating the positioned pump to unload the left ventricle at a pumping rate of at least 2.5 L/min of blood flow for a support period between at least 30 minutes and less than 60 minutes. Then, after the support period, the method comprises applying coronary reperfusion therapy to the heart.


Find Patent Forward Citations

Kapur, Navin. (2026). Systems and methods for left ventricular unloading in treating myocardial infarction (U.S. Patent No. 12544553). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12544553

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…